Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nippon Shinyaku CoTSE:4516 +1.22%92 Return-on-Tangible-Asset is 5.36% as of Mar. 2026, which is 50% below its 10-year median of 10.66. GuruFocus rates TSE:4516 with a GF Score™ of 92/100 and a GF Value™ of 円4,841.97 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 1,008 Drug Manufacturers companies, Nippon Shinyaku Co ranks better than 82.14% on this metric.
Return-on-Tangible-Asset is calculated as Net Income divided by its average total tangible assets. Total tangible assets equals to Total Assets minus Intangible Assets. Nippon Shinyaku Co's annualizedNet Income for the quarter that ended in Mar. 2026 was 円15,508 Mil. Nippon Shinyaku Co's average total tangible assets for the quarter that ended in Mar. 2026 was 円289,074 Mil. Therefore, Nippon Shinyaku Co's annualized Return-on-Tangible-Asset for the quarter that ended in Mar. 2026 was 5.36%.
The historical rank and industry rank for Nippon Shinyaku Co's Return-on-Tangible-Asset or its related term are showing as below:
TSE:4516'
s Return-on-Tangible-Asset Range Over the Past 10 Years
Min: 8.24 Med: 10.66 Max: 13.75
Current: 11.39
During the past 13 years, Nippon Shinyaku Co's highest Return-on-Tangible-Asset was 13.75%. The lowest was 8.24%. And the median was 10.66%.
TSE:4516's Return-on-Tangible-Asset is ranked better than 82.14% of 1008
companies
in the Drug Manufacturers industry
Industry Median: 3.14
vs TSE:4516: 11.39
Nippon Shinyaku Co (TSE:4516) Return-on-Tangible-Asset Explanation
Return-on-Tangible-Asset measures the rate of return on the average total tangible assets (total assets minus intangible assets). Tangible means physical in nature. Intangible Assets are assets that are not physical in nature, and typically "derive their value from legal or intellectual rights." Return-on-Tangible-Asset measures a firm's efficiency at generating profits from its tangible assets. It shows how well a company uses what it has to generate earnings. Return-on-Tangible-Assets can vary drastically across industries. Therefore, Return-on-Tangible-Asset should not be used to compare companies in different industries.
Be Aware
Like ROE and ROA, Return-on-Tangible-Asset is calculated with only 12 months data. Fluctuations in the companys earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. Return-on-Tangible-Asset can be affected by events such as stock buyback or issuance, and by a companys tax rate and its interest payment. Return-on-Tangible-Asset may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high Return-on-Tangible-Asset may indicate vulnerability in the durability of the competitive advantage.
Nippon Shinyaku Co Return-on-Tangible-Asset Related Terms
Nippon Shinyaku Co Return-on-Tangible-Asset Historical Data
* Premium members only.
The historical data trend for Nippon Shinyaku Co's Return-on-Tangible-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:4516 vs ZTS, UTHR: Return-on-Tangible-Asset Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Nippon Shinyaku Co's Return-on-Tangible-Asset, along with its competitors' market caps and Return-on-Tangible-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nippon Shinyaku Co Return-on-Tangible-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Nippon Shinyaku Co's Return-on-Tangible-Asset distribution charts can be found below:
* The bar in red indicates where Nippon Shinyaku Co's Return-on-Tangible-Asset falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Asset, the net income of the last fiscal year and the average total tangible assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is four times the quarterly (Mar. 2026) net income data.
What does a Return-on-Tangible-Asset of 5.36% mean?
Nippon Shinyaku Co (TSE:4516) has a Return-on-Tangible-Asset of 5.36% as of Mar. 2026. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Nippon Shinyaku Co and its competitors. This is 50% below median its historical median of 10.66. Over the past decade, Nippon Shinyaku Co's Return-on-Tangible-Asset has ranged from 8.24 to 13.75. According to the industry distribution chart, Nippon Shinyaku Co ranks #180 out of 1008 companies in the Drug Manufacturers industry, placing it in the top 17.9%.
Is Nippon Shinyaku Co's Return-on-Tangible-Asset too high?
Nippon Shinyaku Co's current Return-on-Tangible-Asset of 5.36% is 50% below median its 10-year median of 10.66. Over the past 10 years, this metric has ranged from a low of 8.24 to a high of 13.75. The Drug Manufacturers industry median Return-on-Tangible-Asset is 3.14. Nippon Shinyaku Co's value of 5.36% is 70.7% above this industry median. Based on the distribution chart, Nippon Shinyaku Co ranks #180 out of 1008 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Nippon Shinyaku Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nippon Shinyaku Co's Return-on-Tangible-Asset compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Nippon Shinyaku Co ranks #180 out of 1008 companies for Return-on-Tangible-Asset. This places Nippon Shinyaku Co in the top 18% of its industry — outperforming the majority of peers. The industry median Return-on-Tangible-Asset is 3.14. Nippon Shinyaku Co's value of 5.36% is 70.7% above this benchmark. Historically, Nippon Shinyaku Co's own Return-on-Tangible-Asset has ranged from 8.24 to 13.75 over the past decade. While the company's 10-year median is 10.66 vs. the industry median of 3.14, Nippon Shinyaku Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Asset for a Drug Manufacturers company?
The median Return-on-Tangible-Asset among Drug Manufacturers companies is 3.14, based on 1,008 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Asset significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nippon Shinyaku Co's current Return-on-Tangible-Asset of 5.36% is 70.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Asset mean?
A high Return-on-Tangible-Asset can signal that a stock is expensive relative to its fundamentals. Return on tangible assets is the ratio of current-period net income to average two-period tangible assets. View historical data on Nippon Shinyaku Co and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Asset is 3.14 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nippon Shinyaku Co's current Return-on-Tangible-Asset is 5.36%, which is 50% below median its own 10-year median of 10.66. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nippon Shinyaku Co stock overvalued right now?
Based on GuruFocus' analysis, Nippon Shinyaku Co (TSE:4516) is currently considered Modestly Undervalued. The stock's GF Value™ is 円4,841.97, compared to a current price of 円4,066.00 — trading 16% below its estimated fair value. The current Return-on-Tangible-Asset is 5.36%, which is 50% below median its 10-year median of 10.66 and 70.7% above the Drug Manufacturers industry median of 3.14. Nippon Shinyaku Co's overall GF Score™ is 92/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Asset calculated?
Return-on-Tangible-Asset is calculated from a company's financial statements. For Nippon Shinyaku Co (TSE:4516), the current Return-on-Tangible-Asset is 5.36% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nippon Shinyaku Co (TSE:4516) Overvalued in 2026?
Based on GuruFocus' analysis, Nippon Shinyaku Co stock appears to be undervalued.
The current stock price of 円4,066.00 is trading 16% below its estimated GF Value™ of 円4,841.97.
GuruFocus considers Nippon Shinyaku Co to be Modestly Undervalued.
Key valuation signals for TSE:4516:
Return-on-Tangible-Asset: 5.36% (50% below median its 10-year median of 10.66)
GF Value™: 円4,841.97 vs. price of 円4,066.00 (16% below fair value)
Industry Position: 70.7% above the Drug Manufacturers median (#180 of 1008)
No single metric tells the full story. See the TSE:4516 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nippon Shinyaku Co Ltd is engaged in the pharmaceuticals and functional food businesses. The Pharmaceuticals Business develops and sells treatments for urological disorders, blood cancer, rare and intractable diseases, and gynecological conditions. The Functional Food Business produces and sells health food ingredients, quality-stabilizing preservatives, protein preparations, and supplements. It generates the majority of its revenue from the Pharmaceuticals segment.
92GF Score
Get the complete analysis for TSE:4516
Return-on-Tangible-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:4516 has been successfully added to your 
